Name: ICTR-PHE 2014
Start: 2014-02-10T12:00:00+01:00
End: 2014-02-14T16:30:00+01:00
Location: Centre International de Conferences de Geneve (CICG)

ICTR-PHE 2014

from Monday, February 10, 2014 (12:00 PM) to Friday, February 14, 2014 (4:30 PM)

Monday, February 10, 2014

12:00 PM Lunch
Lunch
12:00 PM - 1:00 PM
1:00 PM Welcome addresses - Rolf Heuer Manjit Dosanjh Representative of the Geneva state Jacques Bernier
Welcome addresses
- Rolf Heuer
- Manjit Dosanjh
- Representative of the Geneva state
- Jacques Bernier
1:00 PM - 1:30 PM
1:30 PM
1:30 PM - 2:00 PM
Contributions

1:30 PM The Higgs boson and our life - Fabiola Gianotti
2:00 PM
2:00 PM - 4:00 PM
Contributions

2:00 PM Ion Beam Radiobiology: From the Lab to the Clinic - Eleanor Blakely

2:30 PM International Cancer Expert Corps (ICEC) - Norman Coleman

3:00 PM New challenges for biologically adapted ion beam treatment planning: single and multi-ion approaches - Emanuele Scifoni

3:15 PM RBE and DNA damage variation along monoenergetic and modulated Bragg peaks of a 62 MeV therapeutic protons beam - Kevin Prise

3:30 PM Influences of aberrant mitochondrial DNA in cancer and cancer therapy - Marike van Gisbergen

3:45 PM Hpv Status and Effect on Radiosensitivity in Head and Neck Cancer Tumor Xenografts - Brita S Sørensen
4:00 PM Coffee
Coffee
4:00 PM - 4:30 PM
4:30 PM Radiobiology
Radiobiology
4:30 PM - 5:00 PM
Contributions

4:30 PM Rectal cancer and fractionation sensitivity in the neo-adjuvant radiation therapy setting: a project of meta-analysis and radiobiological modeling from individual patient data in randomized and observational data-sets - Raymond Miralbell

4:45 PM A Biomedical Research Facility at CERN based on the Low Energy Ion Ring - Adriano Garonna
5:00 PM Nuclear Medicine
Nuclear Medicine
5:00 PM - 6:15 PM
Contributions

5:00 PM Radiochemical aspects of radionuclide therapies - Helmut Maecke

5:30 PM ²¹²Pb-labeled mAbs targeting CEA or HER2 during α-RIT of small peritoneal carcinomatosis – Dose effect relationship? - Jean-Pierre Pouget

5:45 PM 152/161Tb-DOTA-RM6 biodistribution studies in prostate cancer bearing SCID mice and 149Tb sources from CERN-MEDICIS - Thierry Stora

6:00 PM A radionuclide generator of Erbium-165, an isotope for Auger Therapy - Gregory Severin
Tuesday, February 11, 2014
8:30 AM
8:30 AM - 10:00 AM
Contributions

8:30 AM Clinical experience with radionuclide therapies - Irene Virgolini

9:00 AM From bench to bedside: development and early clinical results of 188Re-SSS/Lipiodol for HCC treatment - Nicolas Lepareur

9:15 AM PIP: a compact recirculating accelerator for the production of medical isotopes - Adina Toader

9:30 AM Gamma Probe Based on Scintillation Crystal and Silicon Photomultiplier - Konstantin Zhukov

9:45 AM Preclinical studies and radiopharmaceutical developments with 64Cu produced by ARRONAX facility - Mickael Bourgeois
10:00 AM Coffee Break
Coffee Break
10:00 AM - 10:30 AM
10:30 AM
10:30 AM - 12:30 PM
Contributions

10:30 AM From CERN to PET/MR - David Townsend

11:00 AM Software challenges and opportunities for multidisciplinary PET/CT and PET/MR imaging - Dimitris Visvikis

11:30 AM Prompt gamma imaging of proton pencil beams at clinical beam current - Julien Smeets

11:45 AM Prediction of β+-activity distributions from PT-PET by means of a yield approach - Stephan Helmbrecht

12:00 PM ProXY – High performance monolithic pixel tracker for proton tomography - Piero Giubilato

12:15 PM The recent developments of the FLUKA Monte Carlo code oriented to its applications in Hadrontherapy - Paola Sala
12:30 PM Lunch
Lunch
12:30 PM - 1:30 PM
1:30 PM Detectors & Imaging
Detectors & Imaging
1:30 PM - 2:15 PM
Contributions

1:30 PM Different detector concepts for several imaging scenarios: from hadrontherapy monitoring to clinical imaging - Paola Solevi

1:45 PM An integrated monitoring system for the on-line assessment of particle therapy treatment accuracy - Vincenzo Patera

2:00 PM Development of Advanced Quality Assurance Instrumentation for Hadrontherapy - David Watts
2:15 PM New Technologies
New Technologies
2:15 PM - 3:45 PM
Contributions

2:15 PM Novel detectors for range assessment in particle therapy - Peter Thirolf

2:45 PM The ELIMED (Multidisciplinary and Medical applications at the ELI-Beams) network perspectives for laser driven beam applications - Andrea Attili

3:00 PM Harnessing laser-plasma accelerated ion beams for applications using Gabor lenses - Christopher Hughes

3:15 PM Positron emission tomography (PET) isotope production from laser-driven proton - John Wong Kai Ding

3:30 PM A novel TOF-PET detector based on organic scintillators - Pawel Moskal
3:45 PM Coffee Break
Coffee Break
3:45 PM - 4:15 PM
4:15 PM New Technologies
New Technologies
4:15 PM - 5:30 PM
Contributions

4:15 PM Requirements from Oncology to Imaging Technologies - Heinz-Peter Schlemmer

4:45 PM Potential of Detection of fast Cherenkov Photons for Improved Time of Flight Positron Emission Tomography - Stefan Brunner

5:00 PM Experimental characterization of acoustic detection and imaging for Bragg peak localization in proton therapy - Katia Parodi

5:15 PM A new elastic image fusion model for lung deformation simulation in 4D dose calculations - Stefan Milz
6:30 PM Physics is beautiful and useful - Ugo Amaldi (TERA Foundation (IT))
Physics is beautiful and useful
- Ugo Amaldi (TERA Foundation (IT))
6:30 PM - 7:30 PM
Room: 2
8:00 PM Cocktail
Cocktail
8:00 PM - 8:45 PM
Wednesday, February 12, 2014
8:30 AM
8:30 AM - 9:00 AM
Contributions

8:30 AM Individualized Radiation Oncology – harnessing clinics, biology and high technology - Michael Baumann
9:00 AM
9:00 AM - 10:00 AM
Contributions

9:00 AM Health implications and applications in space - Christer Fuglesang

9:30 AM The convergence of science - the way to develop novel radiation oncology technologies for the future - Dag Rune Olsen
10:00 AM Coffee Break
Coffee Break
10:00 AM - 10:30 AM
10:30 AM
10:30 AM - 12:00 PM
Contributions

10:30 AM Current status of Carbon Ion Radiotherapy at NIRS - Hirohiko Tsujii

11:00 AM Radioisotopes - the "fuel" for nuclear medicine - Ulli Koster

11:30 AM Medical applications at CERN - Steve Myers
12:00 PM Lunch
Lunch
12:00 PM - 1:00 PM
1:00 PM
1:00 PM - 2:15 PM
Contributions

1:00 PM New insights into the complexities of NHEJ and HR repair - Simon Powell

1:25 PM Homologous recombination deficiency and radio-curability in mouse models for BRCA1/2-deficient breast cancer - Sven Rottenberg

1:50 PM Mechanism of HR dysfunction in single dose radiotherapy - Zvi Fuks
1:00 PM - 2:15 PM
Contributions

1:00 PM New insights in IGRT for prostate cancer - Marcel Van Herk

1:25 PM Adaptive radiotherapy - Vincent Gregoire

1:50 PM New health technologies and evidence-based medicine - Soren Bentzen
2:15 PM Coffee Break
Coffee Break
2:15 PM - 2:45 PM
2:45 PM
2:45 PM - 4:25 PM
Contributions

2:45 PM Carbon Ion Therapy: Actual and Future Strategies at HIT - Jurgen Debus

3:10 PM Present status of CNAO - Roberto Orecchia

3:35 PM Proton Radiation Therapy: Current Status of Clinical Trials - Thomas Delaney

4:00 PM France HADRON: national infrastructure for hadrontherapy research including ETOILE, ARCHADE and protontherapy centers - Jacques Balosso
2:45 PM - 4:25 PM
Contributions

2:45 PM The development of a low energy facility for clinical trials of Boron Neutron Capture Therapy - Rob Edgecock

2:55 PM Interstitial Detectors for Synchronized Radiation Quality - Giulio Magrin

3:05 PM An innovative on-line beam-monitoring detector based on the emission of secondary electrons - Saverio Braccini

3:15 PM Radiotherapy Dose Monitoring to Low-Dose Morphologic Imaging with Scanned Megavoltage X-rays - Paulo Crespo

3:25 PM Data models for the Compton camera acquisition and their influence on the reconstructed images - Voichita Maxim

3:35 PM Detection of ionizing radiation by intrinsic optical fiber sensors: preliminary results - Laura Cella

3:45 PM First investigations of Ultra-Thin 3D silicon detectors as microdosimeters - Celeste Fleta

3:55 PM Frequency difference electrical impedance tomography for imaging lung tumour - Chuan Li Yang

4:05 PM A novel dual-modality optical tomography and x-ray system for small animal radiation research platform - Ken Kang Hsin Wang

4:15 PM Digital Image Processing Techniques for Application in a Microbeam End-Station Microscopy - Antonios Georgantzoglou
4:30 PM
4:30 PM - 6:00 PM
Contributions

4:30 PM DCE-MRI and DCE-US quantification in CWR22 prostate tumour xenografts - Natalia Arteaga-Marrero

4:40 PM Antitumor activity of combination therapy with TH-302 and irradiation in a rat rhabdomyosarcoma model - Sarah Peeters

4:50 PM Development of a novel ELISA for detecting inducible Hsp70 in serum - Stephanie Ertl

5:00 PM Advancing the small animal radiation research platform for pre-clinical radiation research - John Wong

5:10 PM Evaluation of Late Toxicity Risk for RT Patients through Geant 4 Simulation of X-Ray Dose Deposition - Frederic Brochu

5:20 PM Log file based dose calculations as a quality assurance tool in scanned beam proton radiotherapy - Gabriel Meier

5:30 PM A Novel Radioguided Surgery Technique Exploiting - decays - Riccardo Faccini

5:40 PM Investigation of irregular motion influence for future 4D In-beam PET imaging - Yuan Tian

5:50 PM Ongoing investigations on ion-based radiography and tomography - Lorena Magallanes
4:30 PM - 6:10 PM
Contributions

4:30 PM Initial Qualification of the Irradiation Uncertainties in Ion Beam Therapy of Prostate Cancer - Antoni Rucinski

4:40 PM Can particle beam therapy be improved using helium ions? - A treatment planning study focusing on pediatric patients - Barbara Knaeusl

4:50 PM MCTP: a new Monte Carlo-based treatment planning tool for hadrontherapy - Giusseppe Battistoni

5:00 PM PlanIt: Planning Ion therapy open platform for treatment plans testing and comparing - Faiza Bourhaleb

5:10 PM Robustness of range prediction in proton therapy using prompt gamma emission - Fiere Janssen

5:20 PM Simulation of Hadrontherapy In-beam monitoring at CNAO with the INSIDE detector - Piergiorgio Cerello

5:30 PM Evaluation of existing ripple filter designs for clinical use at the MedAustron ion beam therapy facility - Loic Grevillot

5:40 PM The (non-) detectability of failures in motion mitigated ion beam delivery by means of in-beam PET - Kristin Stützer

5:50 PM Assessment and improvements of Geant4 models in the context of prompt-gamma hadrontherapy monitoring - George Dedes

6:00 PM Monte Carlo modelling of whole-body secondary cancer risk for conventional and emergent radiotherapy - Richard Hugtenburg
7:00 PM Gala Dinner
Gala Dinner
7:00 PM - 10:00 PM
Thursday, February 13, 2014
8:15 AM
8:15 AM - 8:50 AM
Contributions

8:15 AM Host and Tumor Immunity: Local and Systemic Opportunities to Enhance Tumor Curability by Radiotherapy - Ralph Weichselbaum
8:50 AM
8:50 AM - 10:05 AM
Contributions

8:50 AM Identification of new therapeutic targets - Conchita Vens

9:15 AM Single-dose radiotherapy: from learning curve to long-term clinical outcome - Carlo Greco

9:40 AM From bench to bedside: experience of the glioblastoma model for the optimization of radiosensitization - Elizabeth Moyal
8:50 AM - 10:05 AM
Contributions

8:50 AM Hypoxia-induced gene expression - Marianne Koritzinsky

9:15 AM Impact of tumor autophagy on solid tumors response to IR: role of the tumor stroma - Eric Deutsch

9:40 AM Hypoxia: where to go from here? - Jens Overgaard
10:05 AM Coffee Break
Coffee Break
10:05 AM - 10:30 AM
10:30 AM
10:30 AM - 11:50 AM
Contributions

10:30 AM The new business model of the EORTC - Emad Shash

10:50 AM The Radiation Oncology Group of the EORTC: from the past to the future - Philippe Maingon

11:10 AM The new drug and radiotherapy working party - Conchita Vens

11:30 AM An example of the integrated model: the EORTC DAHANCA-1219 trial - Vincent Gregoire
10:30 AM - 11:50 AM
Contributions

10:30 AM Enhanced RBE of sub-micrometer focused low-LET protons - Thomas Schmid

10:40 AM Expression of common or species specific DNA damage-repair pathway related genes in thymus of low-dose-rate irradiated AKR/J and ICR mice - Hee Sun Kim

10:50 AM [18F] HX4 PET imaging of tumour hypoxia in HNSCC patients - Karen Zegers

11:00 AM Inhibition of tumour growth using the small molecule Cathepsin L inhibitor, KGP94 - Thomas Wittenborn

11:10 AM Delayed and Persistent Response of Human Mitochondria after Single Exposure to 0.5 to 4 Gy of Gamma Radiation - Winnie Kam

11:20 AM Dosimetric considerations to determine the optimal technique for localized prostate cancer - Peter Kuess

11:30 AM Auger electron emitters labeled to monoclonal antibodies trigger cell membrane-mediated bystander effects - Jean-Pierre Pouget

11:40 AM Comparing Ion Computed Tomography under clinical constraints - David Hansen
10:30 AM - 11:50 AM
Contributions

10:30 AM Ultimate Time Resolution in Time-of-Flight PET - Paul Lecoq

10:40 AM Ultrafast PET Detectors Based on Digital SiPMs and Their Use in In-Situ PET and Prompt Gamma Ray Imaging - Dennis Schaart

10:50 AM 4D Dose calculations and 4D PET image reconstruction using deformable tetrahedral models of moving organs - Petre Manescu

11:00 AM Motion compensated reconstructions in PET-based ion beam treatment verification for moving target - Chiara Gianoli

11:10 AM Usage of long axial crystals for PET applications: the AX-PET demonstrator and beyond - Chiara Casella

11:20 AM Realistic on-the-fly dose calculation for low energy X-rays Intra-Operative Radiation Therapy - Marie Vidal

11:30 AM A single device for mechanical and radiation Quality Assurance measurements of medical accelerators - Ernesto Valverde John Wong

11:40 AM A combined electrical impedance tomography and cone beam CT for radiation therapy monitoring - Manuchehr Soleimani
11:50 AM
11:50 AM - 12:30 PM
Contributions

11:50 AM Oxygen ions achieve better tumour control probability in hypoxic tumours than carbon ions do - Niels Bassler

12:00 PM Direct evaluation of ion beam radiobiological parameters from clinical data: an alternative approach to the RBE - Andrea Attili

12:10 PM Equivalent uniform dose (EUD) based biological optimization for carbon ion therapy - Sarah Brüningk

12:20 PM Variance Based Sensitivity Analysis of Biological Uncertainties in Carbon Ion Therapy - Florian Kamp
11:50 AM - 12:30 PM
Contributions

11:50 AM TOF-PET scanner configurations for quality assurance in proton therapy: a patient case study - Peter Dendooven

12:00 PM Implementation of a GPU Monte Carlo protons transport code for dose calculations: methods and challenges - Daniel Maneval

12:10 PM Fast pencil beam dose calculation for hadron therapy on GPU - Joakim Da Silva

12:20 PM Parameterization of lateral dose profiles for proton therapy application at CNAO - Martina Mori
11:50 AM - 12:30 PM
Contributions

11:50 AM Modelling acute urinary toxicity after radiotherapy for prostate cancer - Tiziana Rancati Viviana Caillo

12:00 PM Mediators associated to the inflammatory response in prostate cancer patients undergoing RT: preliminary results - Bedini Nice

12:10 PM Daily variation in rectal size and position during prostate radiotherapy measured from helical tomotherapy CT scans - Jessica Scaife

12:20 PM Clinical experience with adaptive radiotherapy for muscle invasive bladder cancer - Anne Vestergaard
12:30 PM Lunch
Lunch
12:30 PM - 1:30 PM
1:30 PM
1:30 PM - 2:00 PM
Contributions

1:30 PM The ART of translation - Marcel Verheij
2:00 PM
2:00 PM - 3:15 PM
Contributions

2:00 PM Eulogy of Professor Kian K. Ang - James Cox

2:25 PM Milestones of Pr Kian Ang’s scientific contribution - Jacques Bernier

2:50 PM Molecular biology of head and neck carcinomas: old challenges, new insights - Kevin Harrington
3:15 PM Coffee Break
Coffee Break
3:15 PM - 3:45 PM
3:45 PM
3:45 PM - 4:35 PM
Contributions

3:45 PM Vimentin (EMT Marker Protein) Score As One of Predictors Resistance to Erlotinib and Radiotherapy for Patients with Stage III Non-Small Cell Lung Cancer on A Prospective Phase II Trial - Ritsuko Komaki

3:55 PM Towards simpler and better prediction of relative biological effect (RBE) - Bleddyn Jones

4:05 PM Combined Radiochemotherapeutical Strategies for Microtubule Stabilizing Agent (MSA)-Resistant Tumors - Angela Broggini-Tenzer

4:15 PM Preclinical Assessment of Efficacy of Radiation Dose Redistribution Based on Intratumoral FDG-PET Uptake - Ludwig Dubois

4:25 PM Fat percentage and hand grip strength in lung cancer: the influence on survival and toxicity - Kim Smits
3:45 PM - 4:35 PM
Contributions

3:45 PM Verification of dynamictrajectory radiotherapy based on Monte Carlo - Michael Fix

3:55 PM Development of a transparent photon detector for the online monitoring of IMRT beams - Rachel Delorme

4:05 PM An Intensity Modulated Radiotherapy Beam Monitoring System using a Monolithic Active Pixel Sensor - Johannes Velthuis

4:15 PM Geant4 simulation of a dedicated beam line at the CNAO facility for the study of uveal melanomas - Edoardo Farina

4:25 PM EndoTOFPET-US: A multimodal ultrasound and time of flight PET endoscope for developing new biomarkers for the prostate and pancreatic cancers - Etiennette Auffray
3:45 PM - 4:35 PM
Contributions

3:45 PM The REQUITE project: validating predictive models and biomarkers of radiotherapy toxicity to reduce side-effects - Tiziana Rancati

3:55 PM Potentiation of radiation response by a novel EGFR/DNA targeting molecule in a triple negative breast cancer model - Beatrice Fournier

4:05 PM Studying inter- and intrafraction motion mitigation with sequential 4D CTs of lung tumor patients - Romain Brevet

4:15 PM Time resolved portal dosimetry for Volumetric Modulated Arc Therapy (VMAT) in lung cancer patients with atelectasis - Mark Podesta

4:25 PM Spot-scanning Proton Therapy for Pediatric Parameningeal Rhabdomyosarcomas: Clinical Outcome of 39 Patients Treated at PSI - Carmen Ares
4:45 PM CERN visit
CERN visit
4:45 PM - 7:00 PM
Room: ATLAS

7:00 PM Cocktail in Globe
Cocktail in Globe
7:00 PM - 8:00 PM
Room: Globe of Science and Innovation
Friday, February 14, 2014
8:30 AM
8:30 AM - 9:45 AM
Contributions

8:30 AM Panel discussion - Hirohiko Tsujii James Cox Jürgen Debus Roberto Orecchia
8:30 AM - 9:45 AM
Contributions

8:30 AM Growth factor and integrin receptor targeting - there is more to it than just inhibition - Nils Cordes

8:55 AM Notch and radiotherapy: does it matter? - Marc Vooijs

9:20 AM Head-and-neck cancers: towards new, intriguing fractionation schedules - Jean Bourhis
9:45 AM Coffee Break
Coffee Break
9:45 AM - 10:15 AM
10:15 AM
10:15 AM - 11:45 AM
Contributions

10:15 AM Radiosensitization of Non–Small Cell Lung Cancers by Targeting Ionizing Radiation-Induced Activation of ADAM17 - Martin Pruschy

10:30 AM Do physiological relevant doses of biguanides have any role in cancer treatment? - Morten Busk

10:45 AM Oral mucosal radiation response (mouse) - relevance of ceramide-induced apoptosis? - Wolfgang Dörr

11:00 AM A phase I/II study of proton and hyperthermia in primary unresectable and recurrent adult soft tissue sarcoma - Niloy Datta
10:15 AM - 11:35 AM
Contributions

10:15 AM Radiobiological Considerations for Retreatment of Central Nervous System Tumours - Bleddyn Jones

10:25 AM Gadolinium based nanoparticles for radiosensitization of head and neck squamous cell carcinoma - Lucie Sancey

10:35 AM Noninvasive Imaging of Radiation-Induced Lung Inflammation with Positron Emission Tomography (PET) in a Murine Model - Jin Zhang Ken Kang Hsin Wang

10:45 AM The use of ‘planned overshoot’ for reducing dose to healthy tissue and improve treatments robustness for scanned proton beams - Francesca Albertini

10:55 AM Clinical testing of an in-room imaging system for patient setup verification in particle therapy - Guido Baroni

11:05 AM Reduced side effects by proton microchannel radiotherapy – study in a human skin model - Stefanie Girst

11:15 AM Entervision Wp4. Biological Dosimetric Phantom. Proof Of Concept Preliminary Results - Thiago Viana Miranda Lima

11:25 AM A knowledge exchange case study: computational radiotherapy at Cambridge - Michael Simmons
10:15 AM - 11:45 AM
Contributions

10:15 AM Intra-fraction tumor tracking based on a surrogate-driven 4D CT motion model in particle radiation therapy - Guido Baroni

10:25 AM Prompt Gamma Imaging at MGH with LaBr3 Scintillating Crystals - Joao Seco

10:35 AM Nanoparticles and protontherapy: disentangling possible physical effects - Yolanda Prezado

10:45 AM 95 MeV/A carbon fragmentation studies for hadrontherapy: measurements and comparisons with GEANT4 simulations - Marc Labalme

10:55 AM Properties of therapeutic He, Li and O beams studied with Geant4 - Lucas Burigo

11:05 AM Automatic beam dose profiler for scanned pencil beams (protons and carbon ions) at the CNAO hadrontherapy facility - Aurora Tamborini

11:15 AM Proton Interaction Vertex Imaging for carbon therapy quality control - Regina Rescigno

11:25 AM Dual energy CT to reduce range uncertainties in hadrontherapy - Guillaume Landry

11:35 AM Research and development of a TOF-based multi-slit collimated camera for online hadrontherapy monitoring - Marco Pinto
11:45 AM Lunch
Lunch
11:45 AM - 12:45 PM
12:45 PM
12:45 PM - 2:00 PM
Contributions

12:45 PM Evolution of technology to optimize the delivery of proton therapy: the third generation - Thomas Bortfeld

1:10 PM Robust optimization of IMPT dose distributions - Radhe Mohan

1:35 PM Proton clinical correlates of patient throughput and cyclotron availability - Kevin McMullen
12:45 PM - 2:00 PM
Contributions

12:45 PM Hypoxia Imaging - Marianne Nordsmark

1:10 PM Functional image-based target definition - Robert Jeraj

1:35 PM Predictive and prognostic role of functional imaging of head and neck squamous cell carcinomas - David Brizel
12:45 PM - 2:00 PM
Contributions

12:45 PM Hypoxia modification in experimental tumours - Daniel Zips

1:10 PM The vascular supply and microenvironment of tumours and their significance for cancer therapy - Michael Horsman

1:35 PM Targeting hypoxia through autophagy - Kasper Rouschop
2:00 PM
2:00 PM - 3:15 PM
Contributions

2:00 PM Biomarker for stratification in radiotherapy - preclinical and early clinical models - Mechthild Krause

2:25 PM Imaging for prescription function - Daniela Thorwarth

2:50 PM How will we develop the evidence base for biologically individualized radiotherapy? - Tim Maughan
2:00 PM - 3:20 PM
Contributions

2:00 PM Carbonic Anhydrase IX inhibitors: a new class of targeted agents - Philippe Lambin

2:20 PM Immunosensitization by radiotherapy: the example of immunocytokines - Ludwig Dubois

2:40 PM Novel strategies to spare normal tissues from radiation damage - Marie-Catherine Vozenin

3:00 PM Intestinal Stem Cells are Radiation Resistant - Richard Kolesnick
3:20 PM Concluding remarks - Manjit Dosanjh (CERN) Jacques Bernier
Concluding remarks
- Manjit Dosanjh (CERN)
- Jacques Bernier
3:20 PM - 3:40 PM

Choose timezone